Foghorn Therapeutics (FHTX) Other Non-Current Assets (2019 - 2026)

Foghorn Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 8233.33% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 8233.33% YoY), while the FY2025 annual figure was $4000.0, down 99.77% from the prior year.
• Other Non-Current Assets was $2.0 million for Q1 2026 at Foghorn Therapeutics, up from $4000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.4 million in Q4 2022 to a low of $4000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $1.5 million across 5 years, with a median of $1.7 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets plunged 99.77% in 2025, then jumped 8233.33% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $2.4 million in 2022, then fell by 28.21% to $1.7 million in 2023, then changed by 0.0% to $1.7 million in 2024, then slumped by 99.77% to $4000.0 in 2025, then soared by 49900.0% to $2.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.0 million (Q1 2026), $4000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.